Subscribe To Our Free Newsletter |
Zydus receives Mexican regulatory approval for cancer drug – Bhava
Zydus Lifesciencesannounced that the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk), has granted marketing approval for Bhava™, a Bevacizumab biosimilar.